Vivesto AB (STO:VIVE)

Sweden · Delayed Price · Currency is SEK

0.0818

+0.0034 (4.34%)

Apr 14, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017
Pharmaceuticals			6.61M	3.04M	28.87M	3.97M	206.20M
Pharmaceuticals Growth			117.50%	-89.47%	626.79%	-98.07%	1880.59%
Total			6.61M	3.04M	28.87M	3.97M	206.20M
Total Growth			117.50%	-89.47%	626.79%	-98.07%	1880.59%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017
European Union			-	1.02M	-	-	-
Sweden			-	-	-	432.00K	401.00K
Sweden Growth			-	-	-	7.73%	45.29%
USA			-	-	25.65M	-	201.10M
Russia			-	-	545.00K	148.50K	149.00K
Russia Growth			-	-	267.00%	-0.34%	-90.59%
Other Countries			-	-	-	142.50K	193.00K
Other Countries Growth			-	-	-	-26.17%	60.83%
Total			-	1.02M	26.19M	723.00K	201.84M
Total Growth			-	-96.12%	3522.68%	-99.64%	10094.09%

Source: S&P Global Market Intelligence.